Business Description
enVVeno Medical Corp
NAICS : 339113
SIC : 3841
Share Class Description:
NVNOW: Warrants (30/05/2023)Description
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 32.61 | |||||
| Equity-to-Asset | 0.95 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 35.8 | |||||
| 3-Year FCF Growth Rate | 36.8 | |||||
| 3-Year Book Growth Rate | 7.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 29.08 | |||||
| Quick Ratio | 29.08 | |||||
| Cash Ratio | 28.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -73.7 | |||||
| Shareholder Yield % | 0.47 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -62.68 | |||||
| ROA % | -58.12 | |||||
| ROIC % | -925.48 | |||||
| ROC (Joel Greenblatt) % | -1322.58 | |||||
| ROCE % | -65.73 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.58 | |||||
| EV-to-EBIT | -1.05 | |||||
| EV-to-EBITDA | -1.08 | |||||
| EV-to-FCF | -1.45 | |||||
| Earnings Yield (Greenblatt) % | -95.24 | |||||
| FCF Yield % | -25.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NVNOW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
enVVeno Medical Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0.65 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
enVVeno Medical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
enVVeno Medical Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
enVVeno Medical Corp Frequently Asked Questions
What is enVVeno Medical Corp(NVNOW)'s stock price today?
The current price of NVNOW is $0.01. The 52 week high of NVNOW is $0.65 and 52 week low is $0.00.
When is next earnings date of enVVeno Medical Corp(NVNOW)?
The next earnings date of enVVeno Medical Corp(NVNOW) is 2024-07-31 Est..
Does enVVeno Medical Corp(NVNOW) pay dividends? If so, how much?
enVVeno Medical Corp(NVNOW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers